Amit Etkin is CEO & President at Alto Neuroscience, Inc. (ANRO). They have made 1 open-market trade across 1 company since 2024, most recently 2026-05-14.
CIK 0002007795
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
1 open-market purchase totalling $50K since 2024, never a sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| ANRO | 833,949 | $18.3M |
Shares reported on the most recent Form 4, priced at the 2026-05-15 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| ANRO | BUY | 2024-02-06 | 2024-02-07 | $16.00 | $50K | -24.1% | -23.0% | -16.0% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.